KB Investment

KB Investment Co., Ltd. (KBIC) is a prominent venture capital and private equity firm established in 1990 and headquartered in Seoul, South Korea. As a subsidiary of KB Financial Group, it manages over USD 2.6 billion in assets as of December 2023. KBIC focuses its investments on a diverse range of sectors, including consumer products and services, healthcare, information technology, materials, resources, industrials, life sciences, and clean technology, with a geographic emphasis on the United States, Southeast Asia, and Israel. The firm is recognized for its industry thought leadership and extensive network of relationships, enabling it to provide active guidance and support to its portfolio companies in areas such as team building, strategy, operations, and governance.

Park Deok-gyu

Director

Seunghwan Kim

Director

Jiae Lee

Executive Managing Director

Jung Ho Yoo

Executive Managing Director

374 past transactions

Letsur

Seed Round in 2025
Letsur is a company focused on creating automated solutions for artificial intelligence development and data cleaning services. It has developed an AI-based platform designed to enhance business performance across various industries. The platform addresses challenges throughout the entire process, starting from identifying a business problem to setting goals, planning services, implementing solutions, and ongoing operations. By streamlining these processes, Letsur enables businesses to resolve issues more quickly and improve their overall efficiency.

Tesollo

Series A in 2025
Tesollo is a prominent company focused on developing advanced robotic grippers and hand solutions that integrate artificial intelligence and robotics. The company aims to create human-level work systems suitable for diverse applications across multiple industries, including housework, education, and food services. Tesollo specializes in delto grippers, motor controllers, and robotics engineering technology, offering customized automation systems designed to meet the unique requirements of each client. By delivering flexible and stable gripper technology, Tesollo enables its customers to handle a wide range of objects with varying sizes, shapes, and materials efficiently.

Contoro

Series A in 2025
Contoro Robotics is a company focused on developing advanced robotic solutions that integrate artificial intelligence with human intelligence and teleoperation capabilities. The company aims to create a significant global impact by providing technologies that enhance remote control and operation of robots. Its products enable clients to autonomously manage tasks such as picking up cases, recognizing text, and palletizing items, all from anywhere in the world. By leveraging telemanipulation and haptic feedback, Contoro Robotics offers innovative human interfaces that enhance the functionality and usability of its robotic systems, allowing clients to unlock the full potential of remote robotic operations.

Seadronix

Series B in 2025
Seadronix is a developer of autonomous navigation solutions for the maritime industry, leveraging advanced artificial intelligence technologies. The company's innovative systems are designed to minimize human intervention while enhancing safety and efficiency in marine operations. By utilizing a variety of learning data sources, Seadronix's technology provides cost-effective and accurate danger prediction, which can be integrated onto any vessel. This capability enables maritime operators to significantly reduce the risk of accidents, thereby improving overall operational safety. The solutions developed by Seadronix are founded on research by PhD experts in the field, underscoring the company's commitment to advancing maritime navigation through cutting-edge technology.

Selta Square

Series A in 2025
Selta Square is an AI-driven company specializing in drug monitoring solutions. It has developed an intelligent pharmacovigilance platform that aims to enhance the drug safety monitoring process by leveraging advanced artificial intelligence and digital technologies. The platform supports pharmacovigilance experts by automating routine tasks, thereby allowing them to concentrate on critical functions such as adverse case management and medical evaluation of medications. Through these innovative services, Selta Square seeks to improve the efficiency and effectiveness of pharmacovigilance practices in the healthcare industry.

Value of Space

Convertible Note in 2024
Value of Space is a real estate financial service provider specializing in automated property assessments through its advanced AI estimation platform. The company focuses on delivering precise market value estimates for various property types, including commercial, industrial, and residential real estate. Utilizing a multi-tier automatic valuation model, Value of Space employs a combination of single parameter models, multiple linear models, and minimum variance adjustment models to ensure accurate and reliable valuations. By streamlining the investment management process, the company enables clients to access comprehensive real estate information efficiently.

Pin Therapeutics

Series C in 2024
Pin Therapeutics, Inc. is a biotechnology company founded in February 2017 and headquartered in South San Francisco, California. The company is focused on developing therapeutic products that harness protein degradation technology to target immune diseases, cancer, and aging-related conditions. Pin Therapeutics employs advanced screening systems, including its PinE3 platform for E3 ligase identification and the PinGLUE system for molecular glue degrader discovery. With a diverse team comprising experienced professionals from global pharmaceutical and biotech sectors, the company is actively advancing several programs, including selective molecular glue degraders and a PROTAC program. Through its innovative approaches to drug discovery, Pin Therapeutics aims to address critical unmet medical needs while enhancing the efficiency and specificity of protein degradation in therapeutic contexts.

Emocog

Series B in 2024
Emocog is a developer of a digital therapeutic platform focused on addressing cognitive impairment, particularly in dementia patients. The company offers customized cognitive training solutions designed to enhance memory and cognitive abilities for individuals with mild cognitive impairment. Emocog's technology utilizes artificial intelligence to provide offline speaker services that encourage behavioral and lifestyle changes among patients. Additionally, the platform includes software-based cognitive training regimens and diagnostic tools, enabling medical professionals to assess and treat cognitive decline effectively. Through its innovative approach, Emocog aims to improve the quality of life for those affected by dementia.

Hyperaccel

Series A in 2024
HyperAccel specializes in hardware solutions tailored for AI application development. The company designs AI-specific semiconductors, optimizing memory bandwidth usage and enhancing cost efficiency, thereby facilitating real-time task completion for businesses.

Dnotitia

Seed Round in 2024
Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large Language Models (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.

Aldavar

Series A in 2024
ALDAVER provides incredibly realistic personalized surgical training models using innovative biopolymer materials that closely resemble human tissues and 3D printing technology.

AI Spera

Series B in 2024
AI Spera specializes in AI-driven cyber threat intelligence services aimed at enhancing security capabilities for businesses. The company develops a cyber threat intelligence system that delivers real-time insights through advanced machine learning and fraud detection technologies. By analyzing various cyber threats, AI Spera helps organizations safeguard their IT assets and maintain a secure online environment. The company focuses on empowering enterprises to navigate the complexities of cybersecurity, ensuring they are well-equipped to combat potential risks and protect their critical information.

Panmnesia

Series A in 2024
Panmnesia is a Korean startup specializing in the development of advanced chip technology. The company is dedicated to creating intellectual property surrounding a technology known as Compute Express Link, which facilitates the pooling of various devices, including AI accelerator chips, processors, and memory, for large data center operators. By enhancing the interoperability of these systems, Panmnesia aims to enable companies to efficiently harness and integrate a diverse array of system components, optimizing performance and resource utilization in high-capacity computing environments.

KL Cube

Venture Round in 2024
KL Cube is a technology company specializing in AI services. It develops and provides data mining, web services, and AI-based sign language translation technology. This technology uses 3D avatars to translate information from daily life into sign language, enhancing communication and societal participation for the hearing impaired.

Kardome

Series A in 2024
Kardome is a technology company founded in 2018 and headquartered in Mazor, Hamerkaz, Israel. It specializes in voice-control technology that enhances speech recognition in noisy environments. By employing a real-time software beamformer, Kardome's solutions improve the clarity of speech signals from multiple speakers, allowing for high-quality sound output without requiring users to raise their voices or be positioned closely to a microphone. The company's offerings include applications for voice-controlled devices, hands-free speakerphones, tablets, cellphones, and conference call systems. Kardome's innovative algorithms enable users to experience seamless voice control, even amidst background noise and competing sounds, making it suitable for various processing environments.

Firmmit

Series B in 2024
Firmmit is a technology-focused agricultural company specializing in optimizing growth data through secure analysis of agricultural technology information. It operates by providing container farms and hydroponic systems for crop cultivation without soil, using less water than traditional methods. This enables both commercial farmers and home growers to efficiently utilize resources and maximize production capabilities, promoting sustainable farming practices and enhanced crop yields.

Fitogether

Venture Round in 2024
Fitogether is a company that focuses on football data analysis through the development of wearable electronic performance tracking systems. Their technology is designed to monitor the performance of elite football leagues, teams, and players by providing comprehensive data acquisition on player metrics. This includes fitness management features that track players' readiness and support training periodization, as well as performance evaluation capabilities that assess endurance and facilitate tactical analysis. By utilizing a cloud-based platform, Fitogether enables players and coaches to analyze collected data effectively, allowing for informed decisions regarding player workload management and overall performance enhancement.

Rznomics

Venture Round in 2024
Rznomics is a biotechnology company founded by Professor Lee Sung-wook's lab, specializing in the development of ribonucleic acid-based gene therapies. The company focuses on creating innovative biopharmaceuticals aimed at addressing significant medical challenges, particularly in the treatment of liver cancer, various cancers, degenerative neurological diseases, and hereditary disorders. Rznomics has been recognized for its technological advancements and was selected by the TIPS program, highlighting its commitment to addressing medical needs that remain unmet in current healthcare. Through its research and development efforts, Rznomics aims to enable medical practitioners to effectively treat complex conditions such as cancer and Alzheimer's disease.

Pathalys Pharma

Series B in 2024
Pathalys Pharma is a clinical biopharmaceutical company focused on developing innovative therapeutics for late-stage chronic kidney disease, particularly targeting secondary hyperparathyroidism (SHPT). SHPT is a condition characterized by the overactivity of the parathyroid glands, resulting from diseases outside of these glands, leading to excessive production of parathyroid hormone (PTH). The company's lead product, upacicalcet, is a novel calcimimetic designed to improve treatment outcomes for hemodialysis patients by mimicking calcium's effects on tissues through the activation of calcium-sensing receptors found in various human organs. Pathalys aims to address significant unmet medical needs in the management of SHPT, ultimately enhancing the quality of care for patients with end-stage chronic kidney disease.

Allround Doctors

Series A in 2024
Allround Doctors is a digital healthcare startup that develops digital medical devices for cancer patients.

LN Robotics

Series B in 2024
LN Robotics is a technology research firm focused on developing advanced robotic solutions for the healthcare industry. The company specializes in creating surgical robots tailored for various medical applications, including cardiovascular interventions, single-hole surgeries in the oral cavity, and endoscopic procedures in urology. By addressing specific clinical needs, LN Robotics aims to enhance the effectiveness and precision of surgical procedures, ultimately improving patient outcomes and supporting medical professionals in their practices.

Xpanner

Series B in 2024
Xpanner is a developer of a cloud-based construction management platform that integrates various construction technology products into a single solution. By streamlining disparate tools, Xpanner enables construction teams to access and manage data from one point, fostering collaboration among all stakeholders. This approach not only enhances productivity, with an average improvement of 15%, but also boosts management efficiency and safety on construction sites. Additionally, Xpanner's platform emphasizes environmental, social, and governance (ESG) improvements, making it a comprehensive solution for modern construction challenges.

Bright Peak Therapeutics

Series C in 2024
Bright Peak Therapeutics is a biotechnology company focused on developing a range of immunotherapies aimed at treating cancer and autoimmune diseases. The company specializes in creating immuno-cytokines that possess pharmacological properties enabling tissue and cell-specific targeting of cytokine payloads. This innovative approach is designed to enhance the efficacy of treatments, ultimately improving patient outcomes and quality of life. By leveraging its expertise in cytokine therapeutics, Bright Peak aims to advance the field of immunotherapy and provide effective solutions for challenging medical conditions.

Hypersonic Laboratories

Series A in 2024
Hypersonic Laboratories is focused on creating HELIX, an innovative open-world sandbox game that aims to deliver a highly immersive player experience within its metaverse ecosystem. The company's gaming application features a built-in marketplace that allows users to easily buy, sell, and rent virtual items and real estate. Designed for user accessibility, the platform enables players to sign up and start gaming within minutes, facilitating transactions with credit cards without the need for complex wallet setups. Through this approach, Hypersonic Laboratories seeks to simplify entry into the metaverse while enhancing user engagement and interaction.

Stars Tech

Series C in 2024
Traditional de-icers such as salt and calcium chloride are effective, but they also cause economic, health and environmental harms such as iron corrosion, concrete damage, plant sulfurization and respiratory problems. To solve this problem, STAR'S TECH developed and commercialized the world's first eco-friendly de-icing agent using starfish extract. This unique solution provides superior results when compared with other traditional de-icing methods. ECO-ST1 is an eco-friendly de-icing agent made from sea waste starfish. It is developed by researchers at Seoul National University and helps reduce the overhead costs of deicing by up to 90%. 80% of the cost of de-icing is overhead. ECO-ST1 prevents traffic accidents through rapid and continuous melting and minimizes iron corrosion and concrete damage to minimize the cost of repairing roads, bridges, vehicles, and guard rails. It also solves road damage by minimizing plant sulfurization. STAR'S TECH has developed an innovative technology to extract the porous structures from starfish. Unstable chloride ions resulting from deicing are absorbed by these porous structures through electrostatic force. Starfish extract helps control chloride ion concentration, which can otherwise be detrimental to the environment. This technology also enables corrosion inhibitor reaction by using very few anti-corrosion agents. ECO-ST1 is manufactured in a bead form rather than the commonly used flake form. This bead is coated with starfish extract and a diffuser for de-icing. Beads are advantageous because they have greater penetration and de-icing performance. Also, as this starfish-coated bead does not create dust, it does not cause respiratory problems.

NXN Labs

Pre Seed Round in 2024
NXN Labs specializes in developing and operating custom diffusion model technology. The company empowers individuals and businesses to create sophisticated, indistinguishable human images and videos, fostering creativity and self-expression through personal or virtual personas.

CnerG

Funding Round in 2024
CnerG, pronounced as "synergy," is a company focused on facilitating clean energy solutions to help corporations achieve carbon neutrality and meet their renewable energy commitments. It operates a cross-border platform for Environmental Commodities, including Energy Attribute Certificates and carbon credits, catering to global corporations engaged in the voluntary clean energy market. CnerG's marketplace streamlines the procurement of these commodities from over 80 countries, while also offering a range of Software as a Service (SaaS) solutions. These solutions include contract management, market intelligence, and continuous audit capabilities, all supported by CnerG Chain, the company's proprietary blockchain technology. The platform emphasizes decentralized power purchase agreement transactions, enhancing data management, settlements, and secondary trading of renewable energy certificates, thereby increasing operational efficiency and reducing transaction costs for buyers and sellers in the clean energy sector.

Apollon

Seed Round in 2024
Apollon is a company that develops noninvasive continuous glucose monitoring systems, aimed at improving health management for individuals with glucose-related conditions. In addition to its focus on healthcare technology, Apollon specializes in providing flexible software solutions and comprehensive consulting services across various industries. The company enhances marketing strategies by offering tools and expertise that streamline processes and improve operational efficiency. Apollon’s industry-agnostic approach allows it to cater to a diverse range of clients, ensuring that each receives customized solutions designed to address specific challenges and objectives in their marketing efforts.

Gloud

Seed Round in 2024
Gloud offers dental digital and digital practice transformation services.

AGL

Series B in 2024
AGL is a golf technology company that focuses on connecting golf courses globally through its innovative SaaS-based AI platform. This platform facilitates real-time tee-time bookings, streamlining the reservation process for golfers and promoting digital transformation within the golf industry. AGL offers integrated solutions, including a Global Distribution System (GDS), payment processing, and enterprise resource planning (ERP), catering to both domestic and international golf courses. With partnerships established with over 1,000 golf courses across more than 30 countries, AGL aims to enhance the golfing experience and maximize revenue for clubs by providing user-friendly, cloud-based information technology solutions that minimize the need for face-to-face interactions and enable wireless payments.

AGL

Series B in 2024
AGL is a golf technology company that focuses on connecting golf courses globally through its innovative SaaS-based AI platform. This platform facilitates real-time tee-time bookings, streamlining the reservation process for golfers and promoting digital transformation within the golf industry. AGL offers integrated solutions, including a Global Distribution System (GDS), payment processing, and enterprise resource planning (ERP), catering to both domestic and international golf courses. With partnerships established with over 1,000 golf courses across more than 30 countries, AGL aims to enhance the golfing experience and maximize revenue for clubs by providing user-friendly, cloud-based information technology solutions that minimize the need for face-to-face interactions and enable wireless payments.

ReadyPost

Seed Round in 2024
ReadyPost is a general meeting service platform that provides services for real estate general meetings.

IDfy

Series E in 2024
IDfy is a Mumbai-based company specializing in online fraud detection and identity verification services. Founded in May 2011, IDfy employs advanced technologies such as machine learning, anomaly detection, and machine vision to enhance identity authentication and background verification processes. The company's platform is designed to help businesses reduce risks associated with fraud, financial loss, and reputational damage. With the ability to process half a million profiles monthly for over 150 clients across diverse sectors, including fintech, insurance, and e-commerce, IDfy provides tools that ensure safer and more trustworthy transactions. Additionally, the platform aids clients in complying with various regulations, such as KYC and anti-money laundering, while improving the onboarding experience for users.

HeyDealer

Venture Round in 2024
HeyDealer is a price comparison platform for used cars.

Coxwave Align

Seed Round in 2024
Coxwave, founded in 2021, is a leader in analytics for the generative AI industry. Leveraging state-of-the-art data infrastructure and domain expertise, our team operates Coxwave Align, powering analytics for conversational AI products. Coxwave successfully raised a $3.5M seed round led by KB Investment to double down on efforts to support global AI builders and increase R&D in new analytics technology. Coxwave Align is a next-generation product analytics tool for LLM-powered conversational AI products. Leveraging Align AI’s cutting-edge natural language search and robust analytics infrastructure, product builders can easily analyze conversational data to make informed product decisions.

Daan Biotherapeutics

Series A in 2024
DAAN Biotherapeutics is a biopharmaceutical company focused on developing innovative treatments for cancer patients. The company specializes in research and development in the field of cancer therapies, employing a range of approaches such as cell therapies, antibodies, and small molecule inhibitors. DAAN Biotherapeutics is particularly dedicated to immune-oncology, utilizing anticancer immune cell therapies, including natural killer (NK) cells and T cell receptors. Through its independent research infrastructure, the company conducts clinical trials to explore various treatment strategies, aiming to create effective new drugs, particularly for lung cancer. By providing healthcare providers with advanced therapeutic options, DAAN Biotherapeutics seeks to improve outcomes for cancer patients.

DYNE Medical Group

Series B in 2024
DYNE Medical Group is a medical equipment manufacturer specializing in endoscopy devices and artificial intelligence solutions for urological surgery. The company focuses on developing innovative manufacturing technologies that incorporate reusable flexible endoscopes, utilizing a unique optimization design and ultra-precision processing. This advanced approach aims to enhance the effectiveness of endoscopic procedures, facilitating minimally invasive treatments for patients. Additionally, DYNE Medical Group is committed to providing AI-based cancer diagnostics, further supporting healthcare professionals in delivering improved patient care.

Shipda

Venture Round in 2024
Shipda is a provider of integrated logistics management services that focuses on optimizing import transportation for businesses. By leveraging trade guides, transportation infrastructure, and data, the company enhances the efficiency of international logistics for its clients. Shipda's digitalization efforts aim to streamline the logistics process, ensuring companies can effectively manage and transport their cargo. With a commitment to improving logistics operations, Shipda plays a vital role in matching services and facilitating smooth import processes for its customers.

bHaptics

Series C in 2024
bHaptics is a company focused on enhancing the virtual reality experience through advanced haptic technology. It develops a range of wearable devices, including a high-end haptic vest and gloves, designed to create a physical connection between users and the virtual environment. These devices feature multiple feedback points and provide a lag-free wireless connection, allowing for immersive interaction during gaming, music, and movie experiences. By delivering precise haptic feedback in sync with audio-visual elements, bHaptics enables users to engage more deeply with digital content, making virtual experiences more emotionally impactful. The company's products are versatile and compatible with various platforms, catering to a wide audience of gamers and VR enthusiasts.

HME Square

Seed Round in 2023
HME Square is a healthcare technology company specializing in the development of innovative medical diagnostics and devices. Their primary product is a non-invasive glucose monitoring system, which combines photoacoustics, MEMS device technology, and deep learning algorithms to provide accurate and continuous blood glucose measurement without the need for blood sampling or needles. This technology aims to prevent chronic diseases by enabling users to monitor their sugar levels conveniently and effectively, promoting healthier lifestyles.

Essential AI

Series A in 2023
Essential AI develops software solutions that harness the power of artificial intelligence and machine learning to improve efficiency in enterprise workflows. By automating labor-intensive and repetitive tasks, the company aims to simplify business processes and enhance productivity. Essential AI's Large Language Models are designed to support users in addressing complex challenges while incorporating human feedback to refine their applications. The company's technology is accessible in multiple languages, making it adaptable for various business environments and facilitating ease of use. Ultimately, Essential AI seeks to empower organizations by unlocking essential skills and amplifying their societal impact.

Odyssey Therapeutics

Series C in 2023
Odyssey Therapeutics is a biotechnology company focused on the development of next-generation immunomodulators and oncology medicines. By leveraging an integrated drug-hunting engine, the company aims to enhance the efficiency of drug discovery, unlocking high-potential targets while reducing the risk of attrition during the development process. Odyssey is committed to advancing precision medicine in the healthcare sector, with a product pipeline designed to facilitate a faster transition to clinical development, thereby improving treatment options for patients with various health conditions.

Onheal

Series B in 2023
Onheal is a company based in South Korea that specializes in the veterinary sector, focusing on the development and distribution of medicines and medical devices for companion animals. The company operates a healthcare platform aimed at extending the life of pets, offering a range of animal medicines and equipment. Through veterinary research and efficacy tests, Onheal provides essential products that support the health and well-being of companion animals, enabling pet owners to access functional and healthy food options for their dogs and other pets.

B:eat Corp

Series B in 2023
B: eat is a retail automation platform intended to run a robot-based cafe.

Allganize

Series B in 2023
Allganize, Inc. is an enterprise workplace automation company that specializes in AI-driven knowledge management software. Founded in July 2017 and based in Pleasanton, California, Allganize provides a natural language understanding API and conversational AI solutions designed to enhance workflow automation for businesses. The company's platform employs advanced deep learning technology to facilitate cognitive search, sentiment analysis, and keyword extraction, allowing organizations to gain insights into team activities and overarching work patterns. By enabling medium and large enterprises to harness AI capabilities, Allganize helps optimize customer engagement and extract value from unstructured data, ultimately enhancing business operations and customer experiences.

Habit Factory

Series C in 2023
Habit Factory is a South Korean company that specializes in application software designed to analyze users' consumption patterns and financial data. By leveraging big data analytics, the company helps individuals understand their spending habits and encourages savings. Habit Factory also offers an insurance analysis platform that allows users to search for insurance policies using their phone numbers or credit card information. This platform aims to enhance the customer experience in financial services by providing personalized insights and recommendations based on users' financial behaviors. Through its innovative solutions, Habit Factory empowers users to make informed financial decisions.

Novorex

Series A in 2023
Novorex is a biotechnology company focused on the development of small-molecule drugs aimed at treating oncology and neurological diseases. The company employs advanced technologies, including artificial intelligence, to enhance the efficiency of drug development. By integrating biophysical analysis with in vitro and in vivo assays, Novorex aims to create innovative therapeutic solutions for patients with cancer and central nervous system disorders. Through its research and development efforts, Novorex seeks to provide advanced treatment options that meet the needs of patients facing serious health challenges.

Apollon

Seed Round in 2023
Apollon is a company that develops noninvasive continuous glucose monitoring systems, aimed at improving health management for individuals with glucose-related conditions. In addition to its focus on healthcare technology, Apollon specializes in providing flexible software solutions and comprehensive consulting services across various industries. The company enhances marketing strategies by offering tools and expertise that streamline processes and improve operational efficiency. Apollon’s industry-agnostic approach allows it to cater to a diverse range of clients, ensuring that each receives customized solutions designed to address specific challenges and objectives in their marketing efforts.

DoBrain

Series B in 2023
DoBrain is a developer of an innovative online learning platform aimed at enhancing children's education through advanced technology. The platform features an artificial intelligence-based interface that offers brain training and development tests presented in engaging formats such as games and stories. Additionally, DoBrain provides comprehensive brain test reports that analyze a child's cognitive abilities in detail. This approach enables children to learn in an immersive environment, fostering healthy cognitive development and a deeper understanding of new concepts.

Allganize

Series B in 2023
Allganize, Inc. is an enterprise workplace automation company that specializes in AI-driven knowledge management software. Founded in July 2017 and based in Pleasanton, California, Allganize provides a natural language understanding API and conversational AI solutions designed to enhance workflow automation for businesses. The company's platform employs advanced deep learning technology to facilitate cognitive search, sentiment analysis, and keyword extraction, allowing organizations to gain insights into team activities and overarching work patterns. By enabling medium and large enterprises to harness AI capabilities, Allganize helps optimize customer engagement and extract value from unstructured data, ultimately enhancing business operations and customer experiences.

Sound Platform

Series A in 2023
Sound Platform is a company focused on producing and distributing sound sources utilizing advanced sound mastering technology. It specializes in developing a music platform aimed at sound therapy, leveraging artificial intelligence to enhance sound technology. The company's application facilitates the creation and inspection of sound data sets, promoting relaxation and mental well-being for users in their daily lives. Through its innovative approach, Sound Platform aims to improve mental health by integrating therapeutic sound experiences into everyday routines.

Autonomous a2z

Series B in 2023
Autonomous a2z Co., Ltd. is a South Korean company established in 2018, specializing in artificial intelligence-based autonomous driving solutions. Headquartered in Gyeongsan-si, with additional offices in Anyang-si and Sejong City, the company focuses on developing technologies that enable vehicles to recognize their surroundings, assess driving conditions, and execute automatic vehicle control. Its innovative platform supports the commercialization of specialized vehicles, including cleaning trucks, container trucks, and tractors, by providing essential algorithms and services for testing self-driving technologies across Korea. Through its advancements in judgment, control, and recognition technologies, Autonomous a2z aims to enhance mobility and transform the driving experience for general consumers.

BioProtect

Venture Round in 2023
BioProtect Ltd. is an international medical device startup founded in 2004 and headquartered in Israel, with subsidiaries in Germany and the United States. The company specializes in the development and commercialization of biodegradable balloon spacers designed to protect normal tissue during radiation therapy for cancer. Its flagship product, the ProSpace balloon spacer, has received CE marking and demonstrates superior efficacy and safety in safeguarding the rectum during prostate cancer radiation therapy. By creating a temporary separation between the rectum and targeted tissues, BioProtect's technology significantly reduces the risk of serious and chronic side effects associated with radiation treatment while enhancing tumor control. Additionally, the company's platform of biodegradable implantable balloons addresses a variety of unmet clinical needs in the growing radiotherapy spacers market.

XL8

Series A in 2023
XL8 is an artificial intelligence company focused on natural language processing (NLP) services, particularly in media localization. The company has developed a machine translation engine that aims to eliminate language barriers within the media industry. Its platform leverages cloud technologies to facilitate real-time communication and translation, thereby supporting localization companies in delivering efficient translation and localization results. XL8's services are especially beneficial for the Korean media industry, enabling it to expand its reach internationally by ensuring seamless communication across different languages.

Mardi Mercredi

Series A in 2023
Mardi Mercredi is a clothing retailer specializing in easy-to-wear everyday apparel for women, men, and children. The company offers a diverse range of products, including jackets, jeans, tops, shirts, and various accessories. Known for its French-inspired designs, Mardi Mercredi caters to the fashion needs of its customers by providing stylish and practical clothing options that reflect current trends while ensuring comfort and accessibility.

Hyku

Seed Round in 2023
Hyku is a biotechnology company focused on developing small molecule therapeutics that utilize precise covalent targeting to address disease-causing proteins. The company employs a unique platform to identify molecules that covalently bind to non-cysteine amino acids, facilitating the creation of innovative medicines. Hyku's approach aims to tackle significant challenges in the treatment of various diseases, including issues related to selectivity, druggability, and resistance. By advancing the science of covalent medicines, Hyku strives to enhance treatment options and improve patient outcomes.

YEOLHYEOL GANGHO

Seed Round in 2023
YEOLHYEOL GANGHO is dedicated to expanding the universe of the long-running martial arts comic through IP licensing, multimedia content, and brand collaborations. The company focuses on creating new content across various media platforms, including webtoons, web novels, films, and animations. It aims to deliver diverse and engaging experiences to the audience.

Passionate Powerhouse

Seed Round in 2023
Passionate Power as a full-fledged multi-content IP in the future by designing and producing games, cartoons, movies, franchise items, and so on in constant partnership with domestic and overseas partners.

CLE

Seed Round in 2023
CLE is a technology company that specializes in software solutions and imaging technologies for factory automation and artificial intelligence applications. The firm develops advanced vision cameras that enable machines to perceive and interpret their surroundings in a manner akin to human vision. By utilizing images captured by these cameras, CLE's products facilitate 3D reconstruction and modeling services, which are essential for enhancing automation processes. Additionally, the company offers virtual asset integration and human modeling services tailored for the metaverse, positioning itself at the intersection of industrial technology and digital innovation. Through its comprehensive offerings, CLE aims to streamline operations and enhance the capabilities of automated systems across various industries.

Kreemo

Series A in 2023
Kreemo is a manufacturer specializing in the design and production of advanced beamforming antennas. These antennas are engineered to facilitate seamless communication in high-frequency applications, making them suitable for industries such as telecommunications, defense, and satellite communications. Kreemo's products utilize various materials and provide three-sixty-degree performance, thereby enhancing connectivity and functionality for its clients. The company's focus on innovative antenna solutions positions it as a key player in enabling reliable communication across diverse sectors.

WonderWall

Venture Round in 2023
WonderWall is an online art learning platform that connects artists and facilitates the sharing of practical knowledge across various creative disciplines. The platform provides access to a diverse range of online videos covering areas such as music, acting, directing, art, photography, design, and cooking. By offering these resources, WonderWall enables learners to acquire new skills and insights from the comfort of their homes, fostering a community of artists eager to enhance their craft.

Newen AI

Funding Round in 2023
Newen AI, formerly known as RSN, is a leading company in Korea specializing in the analysis of unstructured data through advanced artificial intelligence technologies. With over 20 years of experience, Newen AI has established a significant market presence, assisting a wide range of clients including large and mid-sized companies across various sectors such as electronics, finance, retail, and education. The company offers customized services that encompass brand and market analysis, consumer psychology insights, and sales demand forecasting, among others. It has successfully completed more than 500 projects, currently serving over 200 ongoing clients, with 73% of its customers maintaining long-term relationships lasting over three years. Newen AI's innovative platform employs real-time data aggregation, sentiment analysis, and predictive modeling, enabling organizations to enhance decision-making and optimize their marketing strategies. The firm has demonstrated robust growth, particularly in sales revenue from private companies.

AB180

Series B in 2023
AB180 is a performance marketing firm that specializes in data-driven solutions to enhance business outcomes in the digital landscape. The company has developed a platform that leverages data analytics and marketing technology to help organizations gain insights into customer behavior. By collecting and processing real-time behavioral data from mobile users, AB180 enables businesses to better understand their customers and optimize their marketing strategies. This approach allows organizations to improve their marketing results and adapt effectively to the evolving digital market.

Solvook

Series A in 2023
Solvook is a copyright licensing platform that specializes in providing copyright clearance services for educational materials. The company operates a cloud-based library that offers a diverse range of digital educational resources, allowing users to conveniently access a comprehensive database of knowledge. By streamlining the licensing process, Solvook aims to facilitate the use of copyrighted materials in an educational context, supporting both educators and learners in their pursuit of knowledge.

Hisense Bio

Venture Round in 2023
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.

AIM Future

Series A in 2023
AIM Future specializes in the development of advanced artificial intelligence processors, software, and system integration services. The company is notable for its AI-based NeuroMosAIc Processor (NMP), which is designed for high-performance computing applications. AIM Future's core technology features a scalable and configurable hardware structure built around a RISC-V processor. Additionally, the company offers software development kits (SDKs) that facilitate the implementation and management of neural networks created using popular frameworks such as TensorFlow, Caffe, PyTorch, and ONNX. These solutions enable clients to effectively analyze key performance metrics, including accuracy, memory bandwidth, and run-time efficiency.

STEPPAY

Seed Round in 2023
STEPPAY is a Korean subscription payment platform.

Pilleye

Seed Round in 2023
Pilleye is a technology company specializing in automated pill-counting solutions. Their primary product is a mobile application designed to streamline the pill-counting process, which is often repetitive and time-consuming. The platform employs artificial intelligence to accurately detect and count pills, ranging from half to translucent. This innovation allows healthcare providers and pharmacists to shift their focus towards enhancing patient care by reducing administrative burdens.

DeepLeHR

Seed Round in 2023
DeepLeHR is a developer of a job search platform focused on connecting job seekers with employment opportunities in the manufacturing and technical sectors. The platform enhances the job search process by providing real-time information about various companies and factories, including details on dormitories, commuter buses, union status, and employee reviews. It also offers predictive analytics to assess job fit based on resumes and specific job requirements, enabling recruiting firms to identify suitable candidates efficiently. By sharing interview reviews and pass specifications, DeepLeHR aims to provide tailored job information that supports candidates throughout their entire employment journey.

Tesollo

Series A in 2023
Tesollo is a prominent company focused on developing advanced robotic grippers and hand solutions that integrate artificial intelligence and robotics. The company aims to create human-level work systems suitable for diverse applications across multiple industries, including housework, education, and food services. Tesollo specializes in delto grippers, motor controllers, and robotics engineering technology, offering customized automation systems designed to meet the unique requirements of each client. By delivering flexible and stable gripper technology, Tesollo enables its customers to handle a wide range of objects with varying sizes, shapes, and materials efficiently.

Levit

Series B in 2023
Mobile commerce app that allows customers to have an enjoyable and affordable shopping experience

MangoBoost

Series A in 2023
MangoBoost is a technology company that specializes in advanced system solutions designed to enhance the efficiency of AI data centers. Central to its offerings is the MangoBoost DPU, which enables cost-effective, standards-based AI infrastructure by ensuring compatibility with all commodity GPUs, accelerators, and storage products. This innovation allows for the effective utilization of existing legacy infrastructure and simplifies network systems. Established in 2022, MangoBoost draws on a decade of prior research presented at leading conferences and comprises a team of over 80 professionals, including system architects, software engineers, and FPGA/SoC engineers, many of whom hold doctoral degrees from prestigious institutions and possess significant industry experience with major technology firms. The company has raised more than 60 million US dollars in funding and is actively expanding its operations in the United States, Canada, and South Korea.

Contoro

Seed Round in 2023
Contoro Robotics is a company focused on developing advanced robotic solutions that integrate artificial intelligence with human intelligence and teleoperation capabilities. The company aims to create a significant global impact by providing technologies that enhance remote control and operation of robots. Its products enable clients to autonomously manage tasks such as picking up cases, recognizing text, and palletizing items, all from anywhere in the world. By leveraging telemanipulation and haptic feedback, Contoro Robotics offers innovative human interfaces that enhance the functionality and usability of its robotic systems, allowing clients to unlock the full potential of remote robotic operations.

Playtag

Seed Round in 2023
Playtag operates a proprietary AI-driven platform designed to enhance early childhood education. It analyzes infants' behaviors within kindergarten settings, generating tailored educational insights to support educators and improve learning outcomes for young children.

Xpanner

Series A in 2023
Xpanner is a developer of a cloud-based construction management platform that integrates various construction technology products into a single solution. By streamlining disparate tools, Xpanner enables construction teams to access and manage data from one point, fostering collaboration among all stakeholders. This approach not only enhances productivity, with an average improvement of 15%, but also boosts management efficiency and safety on construction sites. Additionally, Xpanner's platform emphasizes environmental, social, and governance (ESG) improvements, making it a comprehensive solution for modern construction challenges.

PinotBio

Venture Round in 2023
PinotBio, Inc., formerly known as Bionetix, Inc., is a biotechnology company based in Suwon, South Korea, focused on researching and developing innovative small molecule drugs for the ophthalmology and oncology sectors. Established in 2017, the company is engaged in pre-clinical trials for its lead product, NTX-101, which targets glaucoma, alongside other technologies aimed at developing anticancer treatments based on epigenetics. PinotBio's drug development efforts are designed to address refractory and relapsed cancers, as well as other challenging diseases, ultimately enabling healthcare professionals to provide effective therapies for patients facing life-threatening conditions.

Logpresso

Series A in 2023
Logpresso is a cybersecurity company specializing in SecOps platforms designed to enhance security operations for businesses. The company provides a platform that analyzes data and detects cyber threats, allowing organizations to automate their security and IT operations. By streamlining these processes, Logpresso helps companies optimize their resources and improve operational efficiency, making it easier to manage and respond to potential security incidents.

VCAT.AI

Series A in 2023
VCAT.AI is a business-to-business (B2B) subscription software (SaaS) based on AI technology. Create mass marketing creatives as video and banner images just with an product URL or TEXT.

Pion

Series A in 2023
Pion Corporation is a marketing technology company specializing in video intelligence. It offers "Vispot," an AI-driven platform for video creation and ad automation. This application is designed to assist video creatives by providing automated services for video production and optimization. By leveraging artificial intelligence, Pion enables businesses to enhance their marketing capabilities and streamline the video advertising process.

Bigwave Robotics

Series A in 2023
Bigwave Robotics is a developer of robotics devices designed to automate processes.

DotDotDot

Venture Round in 2023
DotDotDot is a South Korean company founded in 2018, specializing in the creation of animated video content for social media platforms. Headquartered in Seoul, the company develops technology that enables users to enhance their communication by incorporating emotions into 3D backgrounds and characters. DotDotDot allows users to share stories through short-form video comics, facilitating a more engaging and interactive way to express ideas compared to traditional photo, video, and text-based social media formats. By focusing on user-generated content and innovative storytelling, DotDotDot aims to transform social interactions in the digital landscape.

Corca AI

Seed Round in 2023
Developer of an AI-based e-commerce advertisement recommendation model designed to provide advertisement recommendation services.

Waiker

Seed Round in 2023
Waiker is a technology company that specializes in providing a comprehensive financial data integration platform aimed at simplifying investment-related activities for individuals. The platform leverages artificial intelligence to enhance the accuracy and timeliness of financial data, ensuring that users have access to critical information with minimal barriers. In addition to its core focus on financial data integration, Waiker offers a range of services, including investment solutions, marketing strategies, cloud security, and IT consulting. This diverse service offering positions Waiker as a multifaceted provider in the financial technology sector, catering to clients seeking innovative and efficient financial solutions.

GrowV

Series A in 2023
GrowV is an education technology company that develops a learning platform designed to cultivate a love for learning among young students. The platform offers personalized educational content in subjects like English, Mathematics, and Korean, delivered via a dedicated tablet tailored for younger ages. This enables children to engage with learning materials suited to their abilities, fostering growth and achievement of their academic goals.

PLAIF

Seed Round in 2023
PLAIF is a company focused on advancing artificial intelligence in industrial robotics. It specializes in developing AI vision products that enhance the compatibility of robots with existing systems through universal middleware. By leveraging deep learning, object recognition, reinforcement learning, and unsupervised learning, PLAIF aims to facilitate seamless interaction between AI robots and humans, enabling full automation of robotic operations across various industries. The company's innovative approach is designed to transform traditional industrial processes, promoting efficiency and productivity through cutting-edge technology.

nonce Classic

Seed Round in 2023
nonce Classic democratizes decentralized tech by funding in and growing early-stage crypto companies in order to expand their market vision. Founded in 2020 and is based in Seoulsi.

M3SEN

Series A in 2023
M3SEN is an artificial intelligence company specializing in 3D image reconstruction and lidar technology services. It develops advanced sensing and deep learning solutions aimed at enhancing productivity in the pig farming industry. By utilizing AI processing, M3SEN monitors adult female pigs in real-time, analyzing extensive data collected from multiple cameras simultaneously. This technology helps farmers address critical issues such as delivery complications, stillbirths, and suffocation risks associated with fetal membranes, ultimately contributing to improved animal welfare and operational efficiency in livestock management.

Stoic Entertainment

Series A in 2023
Developer of online gaming platform designed to enjoy virtual reality content. The company's platform develops VR and metaverse games that provide the desired experience by moving to the desired time and space beyond any time, space, and situation, enabling gamers to enjoy themselves in their leisure time.

Silvia Health

Seed Round in 2023
Silvia Health is an age-tech platform focused on addressing issues related to aging, specifically in the realm of cognitive health. The company utilizes artificial intelligence to facilitate the early detection and treatment of degenerative brain diseases, such as dementia. By employing human-centered technology, Silvia Health empowers individuals to manage their cognitive health effectively within the digital healthcare landscape. Its innovative approach aims to advance the understanding and care of age-related cognitive decline, providing valuable support to clients navigating these challenges.

S&E bio

Series A in 2022
S&E Bio is a biopharmaceutical company specializing in the development of cell therapies aimed at addressing neurological disorders. The company focuses on creating safe and effective treatments using stem cell-derived extracellular vesicles, particularly mesenchymal stem cell-derived therapeutics. S&E Bio targets a range of conditions, including acute stroke, moyamoya disease, chronic stroke, dementia, and cognitive disorders. Through its innovative approach to stem cell therapy, the company seeks to provide advanced treatment options for patients suffering from these incurable diseases, enhancing their quality of life and treatment outcomes.

TainAI

Series A in 2022
TainAI is a technology company that leverages artificial intelligence to enhance financial decision-making for its clients. The company develops a platform that employs natural language processing and machine learning to analyze financial data, offering services such as asset allocation and investment advice. TainAI's mobile application features a portfolio management tool, a comprehensive research library, and a chat-based interface that facilitates real-time interactions, thereby enabling users to engage in simulations and character creation. Through these tools, TainAI aims to transform the financial lives of its users by providing them with the resources needed to make informed investment decisions.

Onthelook

Series A in 2022
Onthelook is a company that operates a fashion-focused mobile application designed to provide users with the latest trends and updates in wearing styles. The platform serves as both a creator tool and a commerce hub for the apparel market, allowing brands and products to gain visibility through various means. By enabling businesses to share their clothing items on the app, Onthelook helps generate revenue by leveraging trending fashion items to drive sales and promotional benefits.

Antigravity

Seed Round in 2022
Antigravity, an underwear vertical platform

Antigravity

Seed Round in 2022
Antigravity innovates user experience by collecting and analyzing human body data with technology.

Wavebridge

Series B in 2022
Wavebridge is an institutional digital asset company founded in November 2018, specializing in both traditional and cryptocurrency finance. The company has developed a digital asset management platform tailored for institutions and corporations, facilitating efficient trade execution and balance management. By connecting digital asset exchanges and blockchain wallets, Wavebridge addresses the challenges faced by corporations and institutions in executing large-volume trades securely and optimally. Additionally, the platform offers reliable accounting and administrative services that adhere to legal and transparent procedures, leveraging advanced data processing and artificial intelligence technology to provide a comprehensive suite of investment solutions.

LBox

Series B in 2022
LBox is a developer of a platform designed to simplify online legal information lookup. Its digital platform functions as a search engine, allowing legal professionals to efficiently access and analyze case law, legal papers, and publications for case-related information.

Xingxing Mobility

Series B in 2022
Xingxing Mobility is a company focused on the development of a micro-mobility application that enhances urban transportation through electric kickboard-sharing services. The platform is designed to provide users with a safe and stable riding experience, allowing for more comfortable and efficient movement in urban environments. By offering electric kickboards, Xingxing Mobility aims to promote convenient and sustainable travel options for its customers.

POSTYPE

Series B in 2022
POSTYPE is a content open market where anyone can sell and buy digital content.

VERTICAH

Seed Round in 2022
Operator of an innovative capital-raising platform intended for startups to gain access to funds. The company's platform promotes genuine growth of companies by making capital more accessible on the basis of future sales, enabling startups to grow and focus on their products by safely raising funds without equity dilution by simply connecting the company and data.

Infinity Care

Seed Round in 2022
Infinity Care digital health care platform makes health checkups more efficient and affordable for consumers. By analyzing medical data collected through various services, the company's technology developed a value healthcare algorithm, providing customers with a technology that allows them to use nearby medical institutions conveniently and at affordable prices through the creation of a value healthcare algorithm, as well as curating health checkups and hospitals for them.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.